The Oncotype DX (ODx) 21-gene recurrence score (RS) is known to be a sound prognostic and predictive assay in node-negative hormonal receptor-positive (HR-positive) and human epidermal growth factor receptor 2 (HER2) negative breast cancer patients. The gene discussed is ERBB2; the disease is breast cancer.